Concepedia

Susan Huyck

SH

Statistics

Publications

33

Citations

3.7K

H-Index

23

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

Nantes Université

Pfizer (Germany)

Translational Research Institute for Metabolism and Diabetes

Susan Huyck is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and clinical trials.

ORCID

Top concepts

Publications per year

2010–2020

33

Publications

33

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

Christopher P. Cannon, Richard E. Pratley, Samuel Dagogo‐Jack et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

Joachim Sieper, Désirée van der Heijde, Maxime Dougados et al. · Arthritis & Rheumatology · 2015 · 218 citations · Full text

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

Christopher P. Cannon, Darren K. McGuire, Richard E. Pratley et al. · American Heart Journal · 2018 · 202 citations · Full text

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial

Robert A. Hauser, Marc Cantillon, Emmanuelle Pourcher et al. · The Lancet Neurology · 2011 · 194 citations

, , +7

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy ( <scp>VERTIS MET</scp> )

Julio Rosenstock, Juan P. Frías, Dénes Páll et al. · Diabetes Obesity and Metabolism · 2017 · 184 citations · Full text

1–5 of 33